e-learning
resources
Amsterdam 2011
Wednesday, 28.09.2011
Translational models of airway disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Consequences of chronic pulmonary TLR9 activation in the lung and beyond
G. Bezemer, D. Fillipov, E. Mortaz, I. van Ark, J. Garssen, A. Kraneveld, F. Ossendorp, G. Folkerts (Utrecht, Leiden, Wageningen, Netherlands)
Source:
Annual Congress 2011 - Translational models of airway disease
Session:
Translational models of airway disease
Session type:
Oral Presentation
Number:
4689
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G. Bezemer, D. Fillipov, E. Mortaz, I. van Ark, J. Garssen, A. Kraneveld, F. Ossendorp, G. Folkerts (Utrecht, Leiden, Wageningen, Netherlands). Consequences of chronic pulmonary TLR9 activation in the lung and beyond. Eur Respir J 2011; 38: Suppl. 55, 4689
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
LSC 2010 Abstract: Defective toll-like receptor-3 (TLR3) function promotes persistent interstitial lung disease and fibrosis in sarcoidosis
Source: Annual Congress 2010 - Sarcoidosis: genes and mechanisms
Year: 2010
Inhibition of microRNA-17 improves lung and heart function in experimental pulmonary hypertension
Source: Annual Congress 2011 - Treatments for pulmonary hypertension in human and experimental models
Year: 2011
Suppressed pulmonary expression of leptin in lipopolysaccharide-induced acute and chronic lung inflammation
Source: Eur Respir Rev 2006; 15: 207-208
Year: 2006
The role of expression of TLR 4 in bleomycin-induced pulmonary fibrosis in mice
Source: Annual Congress 2013 –The role of hormones and cytokines in lung injury
Year: 2013
Biomarkers in pulmonary fibrosis
Source: Annual Congress 2011 - PG20 Biomarkers in respiratory medicine
Year: 2011
Inflammatory response upon viral infection in cystic fibrosis airway epithelial cells
Source: Annual Congress 2010 - Cystic fibrosis: new targets for therapy and impact of viral infections
Year: 2010
Therapeutic hypercapnia prevents pulmonary hypertension in rats with bleomycin-induced chronic neonatal lung injury
Source: Annual Congress 2011 - Resuscitation and ventilation in the baby and infant
Year: 2011
Staphylococcus aureus
enterotoxin B exacerbates cigarette smoke-induced pulmonary inflammation in mice
Source: Annual Congress 2010 - Pathology and immunology of COPD
Year: 2010
P2RX4 signalling enhances acute cigarette smoke-induced lung inflammation and chronic lung emphysema development
Source: International Congress 2019 – Airway inflammation: pharmacological mechanisms and novel targets
Year: 2019
Developing pulmonary rehabilitation in interstitial lung disease
Source: Annual Congress 2010 - PG22 Postgraduate Course: Developing pulmonary rehabilitation in non-COPD patients
Year: 2010
The relationship between PBMC secretion of IFN-alpha following TLR7 and TLR9 activation and lung function in COPD
Source: Annual Congress 2011 - Role of infection in exacerbations of COPD
Year: 2011
Is TGFb a central mediator in the development of pulmonary fibrosis?
Source: Research Seminar 2010 - Novel insights in pulmonary fibrogenesis: from bench to bedside Research Seminar
Year: 2010
Toll like receptor 4 activation upregulates miR-181b attenuating pulmonary fibrosis via targeting TGFBR1
Source: International Congress 2015 – Latest news on miRNAs in pulmonary research
Year: 2015
Suppressed pulmonary expression of leptin in lipopolysaccharide-induced acute and chronic lung inflammation
Source: Annual Congress 2006 - Novel pathogenic aspects of acute lung injury and acute respiratory distress syndrome (ARDS)
Year: 2006
Right lung ischemia induces development of contra-lateral pulmonary vasculopathy
Source: Annual Congress 2011 - Pathobiology of experimental pulmonary hypertension
Year: 2011
Chemokine receptors in a regulation of interstitial lung fibrosis and inflammation
Source: Annual Congress 2008 - Miscellaneous aspects of interstitial lung disease
Year: 2008
Impaired lung NK activity in the lung of Idiopathic Pulmonary Fibrosis patients
Source: Virtual Congress 2021 – Genetics and translational aspects of idiopathic pulmonary fibrosis
Year: 2021
Involvement of the Hedgehog signalling pathway in idiopathic pulmonary fibrosis
Source: Annual Congress 2011 - Growth factors and fibrogenesis: are they good, bad or both?
Year: 2011
Which treatment for which patient with an acute exacerbation of pulmonary hypertension?
Source: Annual Congress 2010 - The acute right heart syndrome in the intensive care unit: a hidden world?
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept